Mirae Asset Global Etfs Holdings Ltd. Dynavax Technologies Corp Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 84,796 shares of DVAX stock, worth $1.13 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
84,796
Previous 82,590
2.67%
Holding current value
$1.13 Million
Previous $920,000
17.61%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding DVAX
# of Institutions
288Shares Held
131MCall Options Held
507KPut Options Held
374K-
Black Rock Inc. New York, NY21.9MShares$292 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$237 Million10.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.16MShares$122 Million0.0% of portfolio
-
State Street Corp Boston, MA7.79MShares$104 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ6.56MShares$87.5 Million5.31% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.69B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...